1. Home
  2. HLIT vs ABCL Comparison

HLIT vs ABCL Comparison

Compare HLIT & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$14.37

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.30

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLIT
ABCL
Founded
1988
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
HLIT
ABCL
Price
$14.37
$5.30
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$14.67
$8.40
AVG Volume (30 Days)
4.5M
7.2M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
0.07
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$42.73
N/A
Revenue Next Year
$18.36
$21.85
P/E Ratio
$192.86
N/A
Revenue Growth
N/A
160.56
52 Week Low
$7.80
$2.75
52 Week High
$17.68
$6.79

Technical Indicators

Market Signals
Indicator
HLIT
ABCL
Relative Strength Index (RSI) 53.82 51.15
Support Level $9.44 $3.42
Resistance Level $15.39 $5.63
Average True Range (ATR) 1.16 0.55
MACD -0.31 -0.11
Stochastic Oscillator 27.09 13.48

Price Performance

Historical Comparison
HLIT
ABCL

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: